Cargando…
Heterogeneity of Vaccine-Induced Immune Thrombotic Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination and Safety of Second Vaccination with BNT162b2
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Georg Thieme Verlag KG
2021
|
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820842/ https://www.ncbi.nlm.nih.gov/pubmed/34794199 http://dx.doi.org/10.1055/a-1701-2926 |
| _version_ | 1784646291701104640 |
|---|---|
| author | Lindhoff-Last, Edelgard Schoenborn, Linda Piorkowski, Michael Herold, Joerg Greinacher, Andreas Sheppard, Jo-Ann Warkentin, Theodore E. |
| author_facet | Lindhoff-Last, Edelgard Schoenborn, Linda Piorkowski, Michael Herold, Joerg Greinacher, Andreas Sheppard, Jo-Ann Warkentin, Theodore E. |
| author_sort | Lindhoff-Last, Edelgard |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8820842 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Georg Thieme Verlag KG |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88208422022-02-09 Heterogeneity of Vaccine-Induced Immune Thrombotic Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination and Safety of Second Vaccination with BNT162b2 Lindhoff-Last, Edelgard Schoenborn, Linda Piorkowski, Michael Herold, Joerg Greinacher, Andreas Sheppard, Jo-Ann Warkentin, Theodore E. Thromb Haemost Georg Thieme Verlag KG 2021-11-18 /pmc/articles/PMC8820842/ /pubmed/34794199 http://dx.doi.org/10.1055/a-1701-2926 Text en The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. ( https://creativecommons.org/licenses/by-nc-nd/4.0/ ) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited. |
| spellingShingle | Lindhoff-Last, Edelgard Schoenborn, Linda Piorkowski, Michael Herold, Joerg Greinacher, Andreas Sheppard, Jo-Ann Warkentin, Theodore E. Heterogeneity of Vaccine-Induced Immune Thrombotic Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination and Safety of Second Vaccination with BNT162b2 |
| title | Heterogeneity of Vaccine-Induced Immune Thrombotic Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination and Safety of Second Vaccination with BNT162b2 |
| title_full | Heterogeneity of Vaccine-Induced Immune Thrombotic Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination and Safety of Second Vaccination with BNT162b2 |
| title_fullStr | Heterogeneity of Vaccine-Induced Immune Thrombotic Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination and Safety of Second Vaccination with BNT162b2 |
| title_full_unstemmed | Heterogeneity of Vaccine-Induced Immune Thrombotic Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination and Safety of Second Vaccination with BNT162b2 |
| title_short | Heterogeneity of Vaccine-Induced Immune Thrombotic Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination and Safety of Second Vaccination with BNT162b2 |
| title_sort | heterogeneity of vaccine-induced immune thrombotic thrombocytopenia after chadox1 ncov-19 vaccination and safety of second vaccination with bnt162b2 |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820842/ https://www.ncbi.nlm.nih.gov/pubmed/34794199 http://dx.doi.org/10.1055/a-1701-2926 |
| work_keys_str_mv | AT lindhofflastedelgard heterogeneityofvaccineinducedimmunethromboticthrombocytopeniaafterchadox1ncov19vaccinationandsafetyofsecondvaccinationwithbnt162b2 AT schoenbornlinda heterogeneityofvaccineinducedimmunethromboticthrombocytopeniaafterchadox1ncov19vaccinationandsafetyofsecondvaccinationwithbnt162b2 AT piorkowskimichael heterogeneityofvaccineinducedimmunethromboticthrombocytopeniaafterchadox1ncov19vaccinationandsafetyofsecondvaccinationwithbnt162b2 AT heroldjoerg heterogeneityofvaccineinducedimmunethromboticthrombocytopeniaafterchadox1ncov19vaccinationandsafetyofsecondvaccinationwithbnt162b2 AT greinacherandreas heterogeneityofvaccineinducedimmunethromboticthrombocytopeniaafterchadox1ncov19vaccinationandsafetyofsecondvaccinationwithbnt162b2 AT sheppardjoann heterogeneityofvaccineinducedimmunethromboticthrombocytopeniaafterchadox1ncov19vaccinationandsafetyofsecondvaccinationwithbnt162b2 AT warkentintheodoree heterogeneityofvaccineinducedimmunethromboticthrombocytopeniaafterchadox1ncov19vaccinationandsafetyofsecondvaccinationwithbnt162b2 |